Terbinafine 1% Cream Dosing for Skin Fungal Infections
For most superficial dermatophyte skin infections, apply terbinafine 1% cream once daily for 1 week, with the specific location determining whether twice-daily application is needed for athlete's foot between the toes. 1
Dosing by Infection Site
Athlete's Foot (Tinea Pedis)
Between the toes (interdigital): Apply twice daily for 1 week 1
Bottom or sides of foot: Apply twice daily for 2 weeks 1
Jock Itch (Tinea Cruris) and Ringworm (Tinea Corporis)
- Apply once daily for 1 week 1
- Achieves 84.2% mycological cure rate versus 23.3% with placebo 4
- For tinea cruris specifically, demonstrates ~94% mycological cure 5
Age Restrictions
Application Instructions
The FDA label provides specific guidance 1:
- Wash affected skin with soap and water
- Dry completely before applying
- For athlete's foot: wear well-fitting, ventilated shoes and change shoes/socks at least once daily
- Wash hands after each use
Key Clinical Considerations
Why such short duration works: Terbinafine is fungicidal (not merely fungistatic like azoles), allowing dramatically shorter treatment courses 6, 7. The allylamine mechanism provides residual antifungal activity in tissue after cessation, with mycological cure rates actually improving post-treatment 7.
Common pitfall: The evidence provided focuses heavily on oral terbinafine and tinea capitis (scalp infections), which require different dosing 8. Do not confuse these oral regimens with topical cream dosing for skin infections.
Treatment failure considerations: If no improvement occurs after the recommended duration, consider:
- Non-compliance with application instructions
- Misdiagnosis (non-dermatophyte infection)
- Emerging terbinafine resistance (increasingly reported globally) 9, 10
- Microsporum species (less responsive to terbinafine than Trichophyton) 8
Resistance alert: Recent data shows increasing terbinafine resistance, particularly in Trichophyton species with SQLE gene mutations 9, 10. If treatment fails, mycological confirmation and susceptibility testing should be considered before retreatment.
The once-daily dosing for most indications (except interdigital athlete's foot) combined with the 1-week duration significantly improves compliance compared to traditional 4-week azole regimens 4, 2, which directly impacts real-world cure rates and reduces community transmission.